| |
 |
 Appeared in Latimes.
The pills are available over the counter in more than a dozen
countries. France offers them in schools, to girls as young as 12.
But large drug companies shied away from distributing them in this
country, to avoid controversy and because they were not highly
profitable.
For years, some family-planning clinics would cut up packets of
birth control pills to use as morning-after pills. In 1997, the Food
and Drug Administration declared the regimen safe, and it took the
unusual step of putting out a notice seeking a company willing to
produce a morning-after pill.
Roderick Mackenzie, a former drug company executive, took up the
offer and founded Gynetics, which in 1998 won approval for the first
morning-after pill, known as Preven. The next year, the drug agency
approved Plan B, a pill distributed by Women's Capital, formed by
women's health advocates.
Without the money to advertise the pill, the companies began urging
its use at college health clinics and family planning clinics.
Women's Capital did not offer Plan B to retail pharmacies until two
years after it was approved.
"We did it upside down," said Sharon Camp, the company's chief
executive. "Usually you start with the high-profit prescribers, then
it trickles down to the public health sector. We did it just the
reverse."
Much of the support has come from pharmacists, who argue that they
should be the primary distributors because time is critical in
taking the pills and many women cannot get to their doctors in time.
In 1998, Washington State took advantage of state regulations that
allowed doctors to delegate some tasks to assign to pharmacists the
task of dispensing emergency contraceptives. Doctors issue standing
prescriptions for the drug, and the pharmacists dispense the pills
and monitor the patients. New Mexico, Alaska, and California have
approved similar arrangements.
At Ross Valley Pharmacy in Marin County, Calif., Paul Lofholm had
been cutting up birth control packets for distribution at Planned
Parenthood clinics for years. Now, he says, distributing the
morning-after pill has become a "regular business." A store
pharmacist remains on call around the clock.
Jerry Karbeling, senior vice president of the Iowa Pharmacy
Association, said: "There's a desire, especially from people who are
graduating from pharmacy schools right now, to be involved in
something more than just handing out pills and bottles. We've been
saying for a long time that the pharmacist is the most accessible
health care professional."
Still, some controversy lingers. A few large chain pharmacies have
refused to stock the drug. The American Life League, a group that
opposes both abortion and birth control, says it considers the
morning-after pill an abortion drug. In the Maryland House of
Delegates, a debate this year over allowing pharmacists to
distribute the pills quickly became one about teenage promiscuity
and abortion.
But in general, advocates of abortion rights say it is far easier to
talk about emergency contraception than it is to talk about RU-486
or abortion. Many people who oppose abortions support birth control
as a way to prevent them. The National Right to Life Committee, for
example, the nation's most prominent antiabortion group, has said it
will not take any position on the application to make emergency
contraception available over the counter. Even the American Life
League said it did not plan to oppose approval.
The Food and Drug Administration would not comment on the pending
application, other than to say a decision would probably be made
within 10 months. Some pharmacists and doctors who support the use
of the pill have argued that it will be used as regular birth
control if made over the counter, particular among teenagers. But
studies showed that making it available did not prompt women to use
it repeatedly. Of 540 women in one study, Dr. Camp said, 10 used it
more than once.
The pills disrupt the menstrual cycle and can cause nausea, which
dissuades regular use. So does the price. The morning-after pill
typically costs $20 to $30 a dose, more than the cost of a month's
supply of birth control pills. While the pill has been most popular
among women ages 19 to 29, studies showed it was not widely used by
teenagers.
Gradually, it is gaining acceptance. Thomas Purdon, who as president
of the American College of Obstetricians and Gynecologists
recommended providing advance prescriptions, said some of his
colleagues at first opposed this. But the practice, Dr. Purdon said,
has become more common. "We're gradually breaking down the
barriers."
Sales reflect that. Gynetics said its sales had increased 50 percent
last year. Plan B has sold three million doses since it was approved
in 1999, with the numbers doubling each year. The Alan Guttmacher
Institute estimated that the pills prevented 51,000 abortions in
2000.
< Previous page

May 19, 2003.
|
|